TERUMO CORP/ADR (OTCMKTS: TRUMY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.
TERUMO CORP UNSP/ADR (TRUMY)
NASDAQ:AMEX Investor Relations:
terumo.com/investor/library/index.html
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
TRUMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRUMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRUMY alerts
High impacting TERUMO CORP UNSP/ADR news events
Weekly update
A roundup of the hottest topics
TRUMY
News
- Terumo (TSE:4543): Evaluating Value After Prolonged Share Price Decline [Yahoo! Finance]Yahoo! Finance
- Terumo reports 1H results [Seeking Alpha]Seeking Alpha
- Interventional Oncology Market to Reach $4.38 Billion by 2030 at CAGR 8.55% - Grand View Research, Inc. [Yahoo! Finance]Yahoo! Finance
- OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ TransplantationGlobeNewswire
- Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025PR Newswire